1558 Stock Overview
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | HK$9.34 |
| 52 Week High | HK$10.40 |
| 52 Week Low | HK$7.92 |
| Beta | 0.089 |
| 11 Month Change | 4.24% |
| 3 Month Change | n/a |
| 1 Year Change | n/a |
| 33 Year Change | n/a |
| 5 Year Change | -74.38% |
| Change since IPO | -70.49% |
Recent News & Updates
Recent updates
Shareholder Returns
| 1558 | HK Pharmaceuticals | HK Market | |
|---|---|---|---|
| 7D | -2.7% | 0.07% | -0.6% |
| 1Y | n/a | -10.2% | 9.6% |
Return vs Industry: Insufficient data to determine how 1558 performed against the Hong Kong Pharmaceuticals industry.
Return vs Market: Insufficient data to determine how 1558 performed against the Hong Kong Market.
Price Volatility
| 1558 volatility | |
|---|---|
| 1558 Average Weekly Movement | 5.9% |
| Pharmaceuticals Industry Average Movement | 6.8% |
| Market Average Movement | 8.9% |
| 10% most volatile stocks in HK Market | 19.2% |
| 10% least volatile stocks in HK Market | 4.3% |
Stable Share Price: 1558 has not had significant price volatility in the past 3 months compared to the Hong Kong market.
Volatility Over Time: Insufficient data to determine 1558's volatility change over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 4,891 | Juncai Jiang | www.hec-changjiang.com |
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. develops, manufactures, sells, and markets pharmaceutical products in the therapeutic areas of anti-infection, endocrine and metabolic, and other diseases in the People’s Republic of China. It manufactures and sells active pharmaceutical ingredients; researches and develops pharmaceutical products, and medical devices and drugs, as well as biotechnology; and provides marketing and medical consulting services.
YiChang HEC ChangJiang Pharmaceutical Co., Ltd. Fundamentals Summary
| 1558 fundamental statistics | |
|---|---|
| Market cap | HK$8.22b |
| Earnings (TTM) | HK$1.77b |
| Revenue (TTM) | HK$5.95b |
4.6x
P/E Ratio1.4x
P/S RatioIs 1558 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 1558 income statement (TTM) | |
|---|---|
| Revenue | CN¥5.54b |
| Cost of Revenue | CN¥1.17b |
| Gross Profit | CN¥4.37b |
| Other Expenses | CN¥2.72b |
| Earnings | CN¥1.65b |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.87 |
| Gross Margin | 78.90% |
| Net Profit Margin | 29.74% |
| Debt/Equity Ratio | 23.9% |
How did 1558 perform over the long term?
See historical performance and comparison